How many insider trades does FilingIQ track for ADIL?

FilingIQ tracks 75 Form 4 insider transactions for ADIL (ADIAL PHARMACEUTICALS, INC.), covering filings from Aug 2, 2018 onwards. 4 of those are dated within the last 90 days.

Are ADIL insiders net buyers or net sellers?

Across the full Form 4 history for ADIL, 29 transactions (39%) were open-market purchases and 4 (5%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does ADIL insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.

What sector is ADIL in?

ADIAL PHARMACEUTICALS, INC. (ADIL) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $2.23M.

ADIL insider trading

NasdaqCM Healthcare

ADIAL PHARMACEUTICALS, INC.: insider trade history from SEC Form 4 filings.

Total Form 4 trades

Last 90 days

Buys / sells

39% / 5%

Market cap

$2.23M

About ADIAL PHARMACEUTICALS, INC.

Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. The company's lead product is AD04, a serotonin-3 antagonist, which is in Phase 3 clinical trials for the treatment of alcohol use disorder. It is also involved in the development of drug candidates for non-opioid pain reduction and other diseases and disorders. The company was founded in 2010 and is based in Glen Allen, Virginia.

Company website: www.adial.com

ADIL insider activity at a glance

FilingIQ tracks 75 insider transactions for ADIL in filings since Aug 2, 2018. The most recent transaction is dated Jul 16, 2026.

Across the full history, 29 open-market purchases and 4 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on ADIL insider trades is 59.3/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live ADIL trades on FilingIQ Raw filings on SEC EDGAR

Latest ADIL Form 4 filings

Young Wendy B.

A Sep 21, 2026

Coastlands Capital LP

P Jul 16, 2026

Coastlands Capital LP

P Jul 13, 2026

Coastlands Capital LP

P Jul 1, 2026

Davidson Matt Chief Development Officer

Goodman Tony Chief Operating Officer

A Apr 9, 2026

Shah Vinay Chief Financial Officer

A Apr 9, 2026

Schuyler Kevin

A Apr 9, 2026

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 820

UNITED THERAPEUTICS Corp

THERMO FISHER SCIENTIFIC INC.

NTRA 129

Natera, Inc.

ATTO 123

Attovia Therapeutics, Inc.

CORT 110

CORCEPT THERAPEUTICS INC

TEM 104

Tempus AI, Inc.

Frequently asked

How many insider trades does FilingIQ track for ADIL?: FilingIQ tracks 75 Form 4 insider transactions for ADIL (ADIAL PHARMACEUTICALS, INC.), covering filings from Aug 2, 2018 onwards. 4 of those are dated within the last 90 days.
Are ADIL insiders net buyers or net sellers?: Across the full Form 4 history for ADIL, 29 transactions (39%) were open-market purchases and 4 (5%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does ADIL insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
What sector is ADIL in?: ADIAL PHARMACEUTICALS, INC. (ADIL) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $2.23M.

Methodology & sources

Every ADIL insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.